Myxedema coma is a life-threatening emergency that occurs when severe, untreated hypothyroidism pushes the body into a state of decompensation. Despite the name, most people with myxedema coma are not actually unconscious. Instead, the condition involves a dangerous slowdown of nearly every organ system: body temperature drops, the heart rate slows, breathing becomes shallow, and mental function deteriorates. Even with modern intensive care, mortality rates historically ranged from 30 to 60%, though more recent nationwide hospital data from 2016 to 2020 found an all-cause mortality rate closer to 11.6%.
How Hypothyroidism Becomes a Crisis
Thyroid hormones regulate the speed of your metabolism, touching everything from how fast your heart beats to how efficiently your brain processes information. In ordinary hypothyroidism, the body compensates for low hormone levels by making adjustments elsewhere. Myxedema coma happens when those compensatory mechanisms fail, usually because a second stressor hits an already-struggling system.
The most common trigger is infection, particularly pneumonia or urinary tract infections. Cold weather is another classic precipitant, since a body already running at a low metabolic rate has very little reserve to generate heat. Other documented triggers include surgery, stroke, heart failure, gastrointestinal bleeding, trauma, and significant blood sugar drops. Certain medications can also tip a person with poorly controlled hypothyroidism into crisis. Sedatives, opioids, anesthetics, lithium, and some heart medications are particularly risky because hypothyroidism slows drug metabolism, making normal doses behave like overdoses. COVID infection has also been documented as a trigger in recent years.
In most cases, the person either had undiagnosed hypothyroidism for a long time or stopped taking their thyroid replacement medication. The crisis rarely strikes out of nowhere. There is almost always a period of worsening hypothyroid symptoms beforehand that went unrecognized or untreated.
What Happens in the Body
Without adequate thyroid hormones, the body’s core temperature drops. Hypothermia is one of the hallmarks of myxedema coma, and body temperatures can fall well below 95°F (35°C). The heart slows, sometimes dramatically, and blood pressure may drop as the cardiovascular system loses its ability to maintain normal output. Breathing slows and becomes shallow, allowing carbon dioxide to build up in the blood while oxygen levels fall.
The brain is especially vulnerable. Mental changes range from confusion and sluggishness to genuine unresponsiveness. Reflexes become very slow. Fluid retention causes puffiness throughout the body, particularly in the face, hands, and legs, and can also accumulate around the heart and lungs. Low sodium levels in the blood (hyponatremia) are a frequent finding, as are low blood sugar and elevated cholesterol. TSH levels are typically extremely high in cases caused by a failing thyroid gland, reflecting the pituitary’s desperate attempt to stimulate hormone production.
The gastrointestinal system slows as well, sometimes to the point of ileus, where the intestines essentially stop moving. This combination of failing temperature regulation, cardiovascular collapse, respiratory depression, and altered consciousness is what makes the condition so dangerous.
How It’s Diagnosed
There is no single blood test that confirms myxedema coma. Clinicians rely on a pattern of findings: very high TSH, very low thyroid hormone levels, hypothermia, slow heart rate, low blood pressure, altered mental status, and the presence of a triggering event. A diagnostic scoring system developed by researchers assigns points across five categories: temperature regulation, nervous system function, cardiovascular signs, gastrointestinal symptoms, and metabolic abnormalities. A score of 60 or above on this scale is considered diagnostic, while scores between 45 and 59 suggest a person is at risk. In validation studies, the score of 60 had 100% sensitivity and about 86% specificity for identifying true cases.
Because myxedema coma is rare and can mimic other conditions like sepsis or stroke, diagnosis sometimes comes late. Clinicians who suspect it typically begin treatment before all lab results are back, since delays worsen outcomes significantly.
What Treatment Looks Like
Myxedema coma requires intensive care. The cornerstone of treatment is replacing thyroid hormones intravenously, since the gut may not be absorbing medication reliably. A large initial loading dose of synthetic thyroid hormone is given first, followed by smaller daily doses. In some cases, a faster-acting form of thyroid hormone is added alongside it to help the body respond more quickly.
Beyond hormone replacement, the medical team works to address every system that has been affected. Warming blankets are used to gradually raise body temperature, though rewarming has to be done carefully to avoid dangerous heart rhythm changes. Breathing support, often with a ventilator, may be needed until respiratory drive improves. Intravenous fluids correct low sodium and low blood sugar, and if an infection triggered the crisis, antibiotics are started immediately. Stress-dose steroids are also commonly given, because the adrenal glands may not be functioning well either, and giving thyroid hormones without addressing adrenal insufficiency can be dangerous.
Recovery Timeline
Recovery from myxedema coma is not fast. Mental status typically improves over days to weeks, not hours. In one well-documented case, a patient who experienced seizures during the crisis didn’t begin regaining consciousness until day six, wasn’t transferred out of the ICU until day 25, and experienced lingering profound lethargy for weeks after that. Clinical improvement, meaning the person looks and feels better, generally happens before blood tests normalize. Thyroid hormone levels may not reach the normal range until the end of a hospital stay that can stretch over a month.
Once stable, people who survive myxedema coma require lifelong thyroid hormone replacement, typically at daily doses between 75 and 150 micrograms taken by mouth. The episode itself doesn’t damage the thyroid further, but it serves as a stark reminder that the underlying hypothyroidism needs consistent treatment. Close follow-up with regular blood work is essential in the months after discharge, as doses often need adjustment during recovery.
Who Is Most at Risk
Myxedema coma overwhelmingly affects older adults, particularly women over 60. It occurs more often in winter months, when cold exposure adds stress to an already taxed system. People at highest risk include those who have stopped taking thyroid medication, those who were never diagnosed with hypothyroidism in the first place, and those with additional chronic illnesses like heart failure or diabetes that reduce the body’s ability to cope with metabolic stress.
People who have had their thyroid surgically removed or treated with radioactive iodine are entirely dependent on replacement medication. Missing doses or losing access to medication, whether through illness, hospitalization for another condition, or simply running out of refills, creates a vulnerability that a second stressor can exploit. The condition is rare, but when it occurs, the stakes are extraordinarily high. Recognizing progressive hypothyroid symptoms before they escalate, such as deepening fatigue, increasing cold intolerance, facial puffiness, and mental slowing, is the most effective way to prevent it.